Skip to content
Industry
This is research, not advice. We’re not SEBI-registered.

Smith & Nephew share price today

Smith & Nephew plc · SNN · Healthcare · Medical Devices · price as of the 4 November 2026 close, updated every trading day · results updated weekly · All US stock lists

Smith & Nephew share price: $32.46 at the close on 4 November 2026, −2.3% in a year.

Turning aroundBusiness trend from the last 12 quarters
$32.46Price −2.3% in a year
21.6×P/E over 8.8 years
$3.1 BRevenue (Jun 2026) +4.6% on a year ago
$303 MProfit (Jun 2026) +3.4% on a year ago
14.5%Operating margin flat on a year ago
12%ROE FY25
8.7%ROIC against a 6.8% cost of capital: +1.9 points

Smith & Nephew plc's earnings have grown faster than its share price. Earnings per share grew +52.3% in a year while the price moved −2.3%.

The main question: yearly earnings per share moved +52.3% while the share price moved −2.3%.

The price has been stalling near its high for 1 weeks. Over the last four quarters, results have been improving, with profit +3.4% on a year earlier, and 222% of the last 3 years' profit came in as cash. What will decide it: whether the price catches up with earnings that have already grown.

What is the Smith & Nephew share price today?

Smith & Nephew plc's share price was $32.46 at the close on 4 November 2026. It has been stalling near its high for 1 week. That is 4.6% above its average price over the last 200 trading days.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today Smith & Nephew plc is in stage 3. The phase helps read everything below.

In the last 52 weeks it traded between $26 and $37, and at that close it sat 58% of the way up from that low. Over the past 13 weeks it has done better than the S&P 500, and it has stayed ahead for 1 week in a row.

1Y

Nov 2026: $32.46, 4.6% above its 200-day average. The price has been stalling near its high for 1 week.

  • Price $32.46
  • 50-day avg $28.41
  • 200-day avg $31.04
Nov 2026: $32.46, 4.6% above its 200-day average. The price has been stalling near its high for 1 week.
WeekPrice50-day avg200-day avg
31 Oct 2025$36.82$36.66$30.86
7 Nov 2025$33.23$36.45$31.11
14 Nov 2025$32.69$36.02$31.31
21 Nov 2025$32.99$35.44$31.48
28 Nov 2025$33.28$35.12$31.64
5 Dec 2025$33.48$34.79$31.82
12 Dec 2025$32.63$34.49$31.96
19 Dec 2025$32.82$34.15$32.03
26 Dec 2025$33.04$33.97$32.09
2 Jan 2026$32.88$33.70$32.18
9 Jan 2026$33.57$33.41$32.32
16 Jan 2026$32.70$33.05$32.43
23 Jan 2026$33.31$32.96$32.55
30 Jan 2026$34.14$33.05$32.76
6 Feb 2026$34.69$33.26$32.97
13 Feb 2026$36.18$33.51$33.19
20 Feb 2026$36.13$33.73$33.35
27 Feb 2026$36.90$34.09$33.55
6 Mar 2026$34.31$34.38$33.72
13 Mar 2026$32.96$34.41$33.83
20 Mar 2026$31.94$34.35$33.93
27 Mar 2026$31.64$34.24$33.98
2 Apr 2026$32.14$34.18$34.03
10 Apr 2026$33.48$34.09$34.12
17 Apr 2026$34.36$34.08$34.22
24 Apr 2026$31.57$33.84$34.28
1 May 2026$31.16$33.36$34.31
8 May 2026$29.95$32.79$34.30
15 May 2026$29.54$32.14$34.26
22 May 2026$30.53$31.85$34.21
29 May 2026$29.69$31.61$34.09
5 Jun 2026$30.61$31.39$33.93
12 Jun 2026$30.57$31.28$33.76
18 Jun 2026$30.08$31.11$33.62
26 Jun 2026$30.04$30.72$33.42
2 Jul 2026$30.25$30.38$33.25
10 Jul 2026$30.70$30.23$33.09
17 Jul 2026$30.59$30.21$32.97
24 Jul 2026$30.57$30.24$32.81
31 Jul 2026$31.56$30.44$32.72
7 Aug 2026$30.11$30.43$32.59
14 Aug 2026$29.81$30.47$32.42
21 Aug 2026$29.26$30.33$32.25
28 Aug 2026$28.97$30.21$32.12
4 Sep 2026$28.87$30.10$32.01
11 Sep 2026$27.50$29.96$31.92
18 Sep 2026$27.56$29.72$31.79
25 Sep 2026$26.91$29.35$31.64
2 Oct 2026$26.42$29.02$31.49
9 Oct 2026$27.24$28.53$31.35
16 Oct 2026$29.06$28.28$31.23
23 Oct 2026$30.83$28.26$31.14
30 Oct 2026$29.70$28.31$31.07
4 Nov 2026$32.46$28.41$31.04
Weekly closing price ($) with its 50-day and 200-day averages. The strip under the chart shows the phase: tan sideways, green rising, yellow stalling near a high, orange falling. 1-year window.

3Y

Nov 2026: $32.46, 4.6% above its 200-day average. The price has been stalling near its high for 1 week.

  • Price $32.46
  • 50-day avg $28.41
  • 200-day avg $31.04
Nov 2026: $32.46, 4.6% above its 200-day average. The price has been stalling near its high for 1 week.
WeekPrice50-day avg200-day avg
3 Nov 2023$24.08$24.50$28.41
10 Nov 2023$24.51$24.24$28.31
17 Nov 2023$25.62$24.14$28.24
24 Nov 2023$25.81$24.07$28.18
1 Dec 2023$26.38$24.08$28.13
8 Dec 2023$26.28$24.18$28.06
15 Dec 2023$26.44$24.45$28.01
22 Dec 2023$27.28$24.79$27.96
29 Dec 2023$27.28$25.15$27.93
5 Jan 2024$26.51$25.49$27.89
12 Jan 2024$27.38$26.04$27.88
19 Jan 2024$28.17$26.37$27.87
26 Jan 2024$28.06$26.72$27.86
2 Feb 2024$27.84$26.96$27.81
9 Feb 2024$27.84$27.19$27.73
16 Feb 2024$28.06$27.38$27.62
23 Feb 2024$28.88$27.58$27.55
1 Mar 2024$26.42$27.63$27.43
8 Mar 2024$27.65$27.64$27.31
15 Mar 2024$27.01$27.70$27.25
22 Mar 2024$26.20$27.63$27.15
28 Mar 2024$25.36$27.53$27.07
5 Apr 2024$24.47$27.17$26.90
12 Apr 2024$23.77$26.80$26.72
19 Apr 2024$23.84$26.38$26.53
26 Apr 2024$24.45$26.04$26.39
3 May 2024$24.78$25.64$26.23
10 May 2024$25.22$25.37$26.08
17 May 2024$26.09$25.25$25.97
24 May 2024$24.87$25.02$25.89
31 May 2024$25.33$24.88$25.83
7 Jun 2024$26.34$24.86$25.80
14 Jun 2024$25.31$24.98$25.77
21 Jun 2024$25.32$25.04$25.74
28 Jun 2024$24.78$25.13$25.70
5 Jul 2024$26.81$25.21$25.68
12 Jul 2024$28.40$25.57$25.73
19 Jul 2024$28.29$25.91$25.82
26 Jul 2024$28.93$26.26$25.94
2 Aug 2024$30.46$26.62$26.10
9 Aug 2024$29.87$27.10$26.29
16 Aug 2024$30.23$27.53$26.48
23 Aug 2024$30.88$27.98$26.67
30 Aug 2024$30.85$28.55$26.83
6 Sep 2024$31.48$29.03$26.94
13 Sep 2024$31.50$29.71$27.08
20 Sep 2024$30.57$30.04$27.21
27 Sep 2024$31.12$30.31$27.32
4 Oct 2024$29.99$30.50$27.42
11 Oct 2024$28.41$30.44$27.46
18 Oct 2024$29.56$30.35$27.50
25 Oct 2024$28.37$30.29$27.56
1 Nov 2024$25.24$29.98$27.56
8 Nov 2024$24.29$29.37$27.48
15 Nov 2024$24.89$28.74$27.39
22 Nov 2024$25.31$28.12$27.32
29 Nov 2024$25.78$27.67$27.28
6 Dec 2024$25.36$27.16$27.21
13 Dec 2024$25.53$26.65$27.16
20 Dec 2024$24.66$26.26$27.11
27 Dec 2024$24.79$25.94$27.04
3 Jan 2025$24.42$25.55$26.99
10 Jan 2025$23.95$25.18$26.96
17 Jan 2025$25.29$24.97$26.94
24 Jan 2025$25.08$25.01$26.96
31 Jan 2025$25.38$25.09$26.99
7 Feb 2025$24.67$25.10$27.02
14 Feb 2025$25.70$25.08$27.05
21 Feb 2025$26.13$25.12$27.08
28 Feb 2025$28.96$25.38$27.16
7 Mar 2025$29.86$25.86$27.26
14 Mar 2025$28.57$26.31$27.35
21 Mar 2025$28.13$26.71$27.44
28 Mar 2025$28.05$27.12$27.49
4 Apr 2025$26.31$27.37$27.55
11 Apr 2025$25.85$27.38$27.56
17 Apr 2025$25.93$27.40$27.58
25 Apr 2025$26.64$27.54$27.58
2 May 2025$28.62$27.73$27.58
9 May 2025$28.34$27.80$27.58
16 May 2025$28.88$27.68$27.57
23 May 2025$28.63$27.63$27.54
30 May 2025$28.96$27.64$27.52
6 Jun 2025$30.26$27.78$27.51
13 Jun 2025$29.39$27.95$27.49
20 Jun 2025$28.83$28.16$27.45
27 Jun 2025$30.22$28.57$27.42
3 Jul 2025$30.28$28.93$27.40
11 Jul 2025$30.28$29.29$27.38
18 Jul 2025$30.17$29.43$27.36
25 Jul 2025$31.67$29.72$27.38
1 Aug 2025$30.83$29.94$27.44
8 Aug 2025$36.14$30.56$27.58
15 Aug 2025$36.20$31.29$27.76
22 Aug 2025$37.49$31.97$28.00
29 Aug 2025$37.45$32.78$28.31
5 Sep 2025$38.09$33.43$28.57
12 Sep 2025$37.78$34.22$28.90
19 Sep 2025$36.85$34.90$29.19
26 Sep 2025$35.42$35.50$29.45
3 Oct 2025$36.32$36.04$29.71
10 Oct 2025$35.11$36.49$29.98
17 Oct 2025$36.34$36.67$30.26
24 Oct 2025$36.59$36.70$30.56
31 Oct 2025$36.82$36.66$30.86
7 Nov 2025$33.23$36.45$31.11
14 Nov 2025$32.69$36.02$31.31
21 Nov 2025$32.99$35.44$31.48
28 Nov 2025$33.28$35.12$31.64
5 Dec 2025$33.48$34.79$31.82
12 Dec 2025$32.63$34.49$31.96
19 Dec 2025$32.82$34.15$32.03
26 Dec 2025$33.04$33.97$32.09
2 Jan 2026$32.88$33.70$32.18
9 Jan 2026$33.57$33.41$32.32
16 Jan 2026$32.70$33.05$32.43
23 Jan 2026$33.31$32.96$32.55
30 Jan 2026$34.14$33.05$32.76
6 Feb 2026$34.69$33.26$32.97
13 Feb 2026$36.18$33.51$33.19
20 Feb 2026$36.13$33.73$33.35
27 Feb 2026$36.90$34.09$33.55
6 Mar 2026$34.31$34.38$33.72
13 Mar 2026$32.96$34.41$33.83
20 Mar 2026$31.94$34.35$33.93
27 Mar 2026$31.64$34.24$33.98
2 Apr 2026$32.14$34.18$34.03
10 Apr 2026$33.48$34.09$34.12
17 Apr 2026$34.36$34.08$34.22
24 Apr 2026$31.57$33.84$34.28
1 May 2026$31.16$33.36$34.31
8 May 2026$29.95$32.79$34.30
15 May 2026$29.54$32.14$34.26
22 May 2026$30.53$31.85$34.21
29 May 2026$29.69$31.61$34.09
5 Jun 2026$30.61$31.39$33.93
12 Jun 2026$30.57$31.28$33.76
18 Jun 2026$30.08$31.11$33.62
26 Jun 2026$30.04$30.72$33.42
2 Jul 2026$30.25$30.38$33.25
10 Jul 2026$30.70$30.23$33.09
17 Jul 2026$30.59$30.21$32.97
24 Jul 2026$30.57$30.24$32.81
31 Jul 2026$31.56$30.44$32.72
7 Aug 2026$30.11$30.43$32.59
14 Aug 2026$29.81$30.47$32.42
21 Aug 2026$29.26$30.33$32.25
28 Aug 2026$28.97$30.21$32.12
4 Sep 2026$28.87$30.10$32.01
11 Sep 2026$27.50$29.96$31.92
18 Sep 2026$27.56$29.72$31.79
25 Sep 2026$26.91$29.35$31.64
2 Oct 2026$26.42$29.02$31.49
9 Oct 2026$27.24$28.53$31.35
16 Oct 2026$29.06$28.28$31.23
23 Oct 2026$30.83$28.26$31.14
30 Oct 2026$29.70$28.31$31.07
4 Nov 2026$32.46$28.41$31.04
Weekly closing price ($) with its 50-day and 200-day averages. The strip under the chart shows the phase: tan sideways, green rising, yellow stalling near a high, orange falling. 3-year window.

5Y

Nov 2026: $32.46, 4.6% above its 200-day average. The price has been stalling near its high for 1 week.

  • Price $32.46
  • 50-day avg $28.41
  • 200-day avg $31.04
Nov 2026: $32.46, 4.6% above its 200-day average. The price has been stalling near its high for 1 week.
WeekPrice50-day avg200-day avg
29 Oct 2021$34.75$36.41$40.17
12 Nov 2021$35.59$35.81$39.74
26 Nov 2021$32.85$35.27$39.35
10 Dec 2021$32.59$34.62$38.92
23 Dec 2021$34.04$34.31$38.65
7 Jan 2022$35.31$34.20$38.49
21 Jan 2022$33.92$34.04$38.35
4 Feb 2022$33.84$33.78$38.05
18 Feb 2022$32.59$33.77$37.58
4 Mar 2022$33.23$34.18$37.21
18 Mar 2022$33.26$33.62$36.63
1 Apr 2022$32.29$33.14$36.11
14 Apr 2022$31.13$32.82$35.59
29 Apr 2022$32.40$32.65$35.04
13 May 2022$31.37$32.07$34.51
27 May 2022$32.71$32.15$34.18
10 Jun 2022$29.78$31.90$33.86
24 Jun 2022$28.69$31.19$33.39
8 Jul 2022$27.24$30.43$32.99
22 Jul 2022$28.48$29.52$32.58
5 Aug 2022$26.06$28.56$32.19
19 Aug 2022$25.04$27.32$31.72
2 Sep 2022$24.80$26.48$31.13
16 Sep 2022$24.32$26.01$30.75
30 Sep 2022$23.22$25.10$30.26
14 Oct 2022$22.58$24.33$29.75
28 Oct 2022$24.16$23.80$29.15
11 Nov 2022$25.47$23.77$28.66
25 Nov 2022$26.78$23.82$28.31
9 Dec 2022$27.14$24.55$27.97
23 Dec 2022$26.87$25.31$27.65
6 Jan 2023$28.64$26.00$27.45
20 Jan 2023$28.48$26.83$27.27
3 Feb 2023$28.88$27.49$27.10
17 Feb 2023$27.86$27.82$26.88
3 Mar 2023$29.39$28.16$26.77
17 Mar 2023$28.32$28.53$26.59
31 Mar 2023$27.91$28.45$26.46
14 Apr 2023$29.99$28.58$26.50
28 Apr 2023$32.70$29.18$26.69
12 May 2023$31.63$29.82$26.89
26 May 2023$30.07$30.33$27.16
9 Jun 2023$30.08$30.68$27.37
23 Jun 2023$31.34$31.18$27.68
7 Jul 2023$29.84$31.25$27.94
21 Jul 2023$31.12$30.96$28.33
4 Aug 2023$28.58$30.60$28.68
18 Aug 2023$27.18$30.16$28.90
1 Sep 2023$26.87$29.36$29.04
15 Sep 2023$26.30$28.51$29.07
29 Sep 2023$24.77$27.44$29.00
13 Oct 2023$22.88$26.08$28.83
27 Oct 2023$21.64$24.92$28.55
10 Nov 2023$24.51$24.24$28.31
24 Nov 2023$25.81$24.07$28.18
8 Dec 2023$26.28$24.18$28.06
22 Dec 2023$27.28$24.79$27.96
5 Jan 2024$26.51$25.49$27.89
19 Jan 2024$28.17$26.37$27.87
2 Feb 2024$27.84$26.96$27.81
16 Feb 2024$28.06$27.38$27.62
1 Mar 2024$26.42$27.63$27.43
15 Mar 2024$27.01$27.70$27.25
28 Mar 2024$25.36$27.53$27.07
12 Apr 2024$23.77$26.80$26.72
26 Apr 2024$24.45$26.04$26.39
10 May 2024$25.22$25.37$26.08
24 May 2024$24.87$25.02$25.89
7 Jun 2024$26.34$24.86$25.80
21 Jun 2024$25.32$25.04$25.74
5 Jul 2024$26.81$25.21$25.68
19 Jul 2024$28.29$25.91$25.82
2 Aug 2024$30.46$26.62$26.10
16 Aug 2024$30.23$27.53$26.48
30 Aug 2024$30.85$28.55$26.83
13 Sep 2024$31.50$29.71$27.08
27 Sep 2024$31.12$30.31$27.32
11 Oct 2024$28.41$30.44$27.46
25 Oct 2024$28.37$30.29$27.56
8 Nov 2024$24.29$29.37$27.48
22 Nov 2024$25.31$28.12$27.32
6 Dec 2024$25.36$27.16$27.21
20 Dec 2024$24.66$26.26$27.11
3 Jan 2025$24.42$25.55$26.99
17 Jan 2025$25.29$24.97$26.94
31 Jan 2025$25.38$25.09$26.99
14 Feb 2025$25.70$25.08$27.05
28 Feb 2025$28.96$25.38$27.16
14 Mar 2025$28.57$26.31$27.35
28 Mar 2025$28.05$27.12$27.49
11 Apr 2025$25.85$27.38$27.56
25 Apr 2025$26.64$27.54$27.58
9 May 2025$28.34$27.80$27.58
23 May 2025$28.63$27.63$27.54
6 Jun 2025$30.26$27.78$27.51
20 Jun 2025$28.83$28.16$27.45
3 Jul 2025$30.28$28.93$27.40
18 Jul 2025$30.17$29.43$27.36
1 Aug 2025$30.83$29.94$27.44
15 Aug 2025$36.20$31.29$27.76
29 Aug 2025$37.45$32.78$28.31
12 Sep 2025$37.78$34.22$28.90
26 Sep 2025$35.42$35.50$29.45
10 Oct 2025$35.11$36.49$29.98
24 Oct 2025$36.59$36.70$30.56
7 Nov 2025$33.23$36.45$31.11
21 Nov 2025$32.99$35.44$31.48
5 Dec 2025$33.48$34.79$31.82
19 Dec 2025$32.82$34.15$32.03
2 Jan 2026$32.88$33.70$32.18
16 Jan 2026$32.70$33.05$32.43
30 Jan 2026$34.14$33.05$32.76
13 Feb 2026$36.18$33.51$33.19
27 Feb 2026$36.90$34.09$33.55
13 Mar 2026$32.96$34.41$33.83
27 Mar 2026$31.64$34.24$33.98
10 Apr 2026$33.48$34.09$34.12
24 Apr 2026$31.57$33.84$34.28
8 May 2026$29.95$32.79$34.30
22 May 2026$30.53$31.85$34.21
5 Jun 2026$30.61$31.39$33.93
18 Jun 2026$30.08$31.11$33.62
2 Jul 2026$30.25$30.38$33.25
17 Jul 2026$30.59$30.21$32.97
31 Jul 2026$31.56$30.44$32.72
14 Aug 2026$29.81$30.47$32.42
28 Aug 2026$28.97$30.21$32.12
11 Sep 2026$27.50$29.96$31.92
25 Sep 2026$26.91$29.35$31.64
9 Oct 2026$27.24$28.53$31.35
23 Oct 2026$30.83$28.26$31.14
4 Nov 2026$32.46$28.41$31.04
Weekly closing price ($) with its 50-day and 200-day averages. The strip under the chart shows the phase: tan sideways, green rising, yellow stalling near a high, orange falling. 5-year window.

10Y

Nov 2026: $32.46, 4.6% above its 200-day average. The price has been stalling near its high for 1 week.

  • Price $32.46
  • 50-day avg $28.41
  • 200-day avg $31.04
Nov 2026: $32.46, 4.6% above its 200-day average. The price has been stalling near its high for 1 week.
WeekPrice50-day avg200-day avg
28 Oct 2016$29.71$32.12–
18 Nov 2016$27.73$30.64–
9 Dec 2016$29.80$29.40–
30 Dec 2016$30.08$28.95–
20 Jan 2017$30.24$29.19–
10 Feb 2017$30.19$29.96–
3 Mar 2017$30.58$30.35–
24 Mar 2017$31.46$30.60–
13 Apr 2017$31.79$30.87–
5 May 2017$34.10$31.53$31.11
26 May 2017$34.89$32.68$31.17
16 Jun 2017$35.23$33.77$31.29
7 Jul 2017$34.23$34.59$31.43
28 Jul 2017$35.38$34.89$31.60
18 Aug 2017$35.40$34.96$32.00
8 Sep 2017$37.07$35.28$32.56
29 Sep 2017$36.40$35.79$33.14
20 Oct 2017$38.28$36.48$33.70
10 Nov 2017$35.96$36.98$34.23
1 Dec 2017$35.85$36.74$34.59
22 Dec 2017$34.85$36.38$34.95
12 Jan 2018$35.17$35.59$35.20
2 Feb 2018$35.82$35.49$35.52
23 Feb 2018$36.17$35.38$35.68
16 Mar 2018$37.72$35.92$35.84
6 Apr 2018$37.45$36.65$36.03
27 Apr 2018$39.10$37.50$36.32
18 May 2018$35.85$37.56$36.42
8 Jun 2018$37.03$37.20$36.49
29 Jun 2018$37.53$36.91$36.55
20 Jul 2018$35.47$36.32$36.51
10 Aug 2018$35.20$36.23$36.37
31 Aug 2018$35.83$35.92$36.27
21 Sep 2018$36.88$35.99$36.34
12 Oct 2018$34.56$36.17$36.42
2 Nov 2018$36.21$35.60$36.32
23 Nov 2018$36.21$35.70$36.38
14 Dec 2018$37.65$35.77$36.49
4 Jan 2019$36.73$36.29$36.45
25 Jan 2019$37.85$37.04$36.43
15 Feb 2019$38.09$37.56$36.41
8 Mar 2019$38.49$37.92$36.58
29 Mar 2019$40.11$38.77$36.83
18 Apr 2019$37.99$39.21$37.00
10 May 2019$42.69$39.68$37.34
31 May 2019$42.27$40.51$37.79
21 Jun 2019$43.80$41.42$38.33
12 Jul 2019$43.45$42.77$38.80
2 Aug 2019$45.59$43.51$39.43
23 Aug 2019$47.01$44.54$40.34
13 Sep 2019$46.66$45.68$41.11
4 Oct 2019$46.86$46.83$41.87
25 Oct 2019$43.49$46.98$42.56
15 Nov 2019$43.21$45.63$42.96
6 Dec 2019$44.08$44.68$43.35
27 Dec 2019$48.50$44.61$43.91
17 Jan 2020$49.29$45.84$44.50
7 Feb 2020$48.25$47.51$45.20
28 Feb 2020$45.08$48.45$45.71
20 Mar 2020$30.71$45.36$45.37
9 Apr 2020$40.42$41.39$44.80
1 May 2020$38.28$38.49$44.44
22 May 2020$40.88$37.07$44.08
12 Jun 2020$40.50$39.74$43.76
2 Jul 2020$39.42$40.24$43.21
24 Jul 2020$41.28$40.52$42.68
14 Aug 2020$41.07$40.63$42.36
4 Sep 2020$40.12$40.47$42.17
25 Sep 2020$37.35$40.51$41.82
16 Oct 2020$39.28$39.92$41.22
6 Nov 2020$37.00$38.81$40.33
27 Nov 2020$38.98$38.56$39.70
18 Dec 2020$41.77$39.18$39.22
8 Jan 2021$44.54$40.23$39.84
29 Jan 2021$42.26$41.88$40.35
19 Feb 2021$41.23$42.89$40.64
12 Mar 2021$39.34$42.19$40.58
1 Apr 2021$38.19$40.63$40.30
23 Apr 2021$41.41$39.34$40.30
14 May 2021$42.98$39.88$40.43
4 Jun 2021$42.43$41.25$40.59
25 Jun 2021$43.80$42.72$40.79
16 Jul 2021$41.68$43.20$41.09
6 Aug 2021$38.22$42.53$41.22
27 Aug 2021$38.54$41.14$41.29
17 Sep 2021$36.83$39.55$41.18
8 Oct 2021$34.20$37.46$40.76
29 Oct 2021$34.75$36.41$40.17
19 Nov 2021$34.63$35.54$39.54
10 Dec 2021$32.59$34.62$38.92
31 Dec 2021$34.62$34.25$38.54
21 Jan 2022$33.92$34.04$38.35
11 Feb 2022$32.64$33.80$37.83
4 Mar 2022$33.23$34.18$37.21
25 Mar 2022$32.55$33.33$36.39
14 Apr 2022$31.13$32.82$35.59
6 May 2022$32.31$32.53$34.81
27 May 2022$32.71$32.15$34.18
17 Jun 2022$27.71$31.49$33.60
8 Jul 2022$27.24$30.43$32.99
29 Jul 2022$25.85$29.19$32.43
19 Aug 2022$25.04$27.32$31.72
9 Sep 2022$26.08$26.27$30.96
30 Sep 2022$23.22$25.10$30.26
21 Oct 2022$23.16$24.02$29.45
11 Nov 2022$25.47$23.77$28.66
2 Dec 2022$27.18$24.10$28.15
23 Dec 2022$26.87$25.31$27.65
13 Jan 2023$28.58$26.47$27.35
3 Feb 2023$28.88$27.49$27.10
24 Feb 2023$28.94$27.99$26.82
17 Mar 2023$28.32$28.53$26.59
6 Apr 2023$28.55$28.44$26.47
28 Apr 2023$32.70$29.18$26.69
19 May 2023$31.87$30.16$27.05
9 Jun 2023$30.08$30.68$27.37
30 Jun 2023$32.25$31.36$27.83
21 Jul 2023$31.12$30.96$28.33
11 Aug 2023$28.44$30.43$28.81
1 Sep 2023$26.87$29.36$29.04
22 Sep 2023$25.36$28.04$29.05
13 Oct 2023$22.88$26.08$28.83
3 Nov 2023$24.08$24.50$28.41
24 Nov 2023$25.81$24.07$28.18
15 Dec 2023$26.44$24.45$28.01
5 Jan 2024$26.51$25.49$27.89
26 Jan 2024$28.06$26.72$27.86
16 Feb 2024$28.06$27.38$27.62
8 Mar 2024$27.65$27.64$27.31
28 Mar 2024$25.36$27.53$27.07
19 Apr 2024$23.84$26.38$26.53
10 May 2024$25.22$25.37$26.08
31 May 2024$25.33$24.88$25.83
21 Jun 2024$25.32$25.04$25.74
12 Jul 2024$28.40$25.57$25.73
2 Aug 2024$30.46$26.62$26.10
23 Aug 2024$30.88$27.98$26.67
13 Sep 2024$31.50$29.71$27.08
4 Oct 2024$29.99$30.50$27.42
25 Oct 2024$28.37$30.29$27.56
15 Nov 2024$24.89$28.74$27.39
6 Dec 2024$25.36$27.16$27.21
27 Dec 2024$24.79$25.94$27.04
17 Jan 2025$25.29$24.97$26.94
7 Feb 2025$24.67$25.10$27.02
28 Feb 2025$28.96$25.38$27.16
21 Mar 2025$28.13$26.71$27.44
11 Apr 2025$25.85$27.38$27.56
2 May 2025$28.62$27.73$27.58
23 May 2025$28.63$27.63$27.54
13 Jun 2025$29.39$27.95$27.49
3 Jul 2025$30.28$28.93$27.40
25 Jul 2025$31.67$29.72$27.38
15 Aug 2025$36.20$31.29$27.76
5 Sep 2025$38.09$33.43$28.57
26 Sep 2025$35.42$35.50$29.45
17 Oct 2025$36.34$36.67$30.26
7 Nov 2025$33.23$36.45$31.11
28 Nov 2025$33.28$35.12$31.64
19 Dec 2025$32.82$34.15$32.03
9 Jan 2026$33.57$33.41$32.32
30 Jan 2026$34.14$33.05$32.76
20 Feb 2026$36.13$33.73$33.35
13 Mar 2026$32.96$34.41$33.83
2 Apr 2026$32.14$34.18$34.03
24 Apr 2026$31.57$33.84$34.28
15 May 2026$29.54$32.14$34.26
5 Jun 2026$30.61$31.39$33.93
26 Jun 2026$30.04$30.72$33.42
17 Jul 2026$30.59$30.21$32.97
7 Aug 2026$30.11$30.43$32.59
28 Aug 2026$28.97$30.21$32.12
18 Sep 2026$27.56$29.72$31.79
9 Oct 2026$27.24$28.53$31.35
30 Oct 2026$29.70$28.31$31.07
4 Nov 2026$32.46$28.41$31.04
Weekly closing price ($) with its 50-day and 200-day averages. The strip under the chart shows the phase: tan sideways, green rising, yellow stalling near a high, orange falling. 10-year window.

Price stage: Rising from Oct 2025 to Mar 2026; Sideways from Mar 2026 to Aug 2026; Falling from Aug 2026 to Nov 2026.

Price stage: Sideways from Nov 2023 to Jan 2024; Sideways from Jan 2024 to Mar 2024; Falling from Mar 2024 to Jun 2024; Sideways from Jul 2024 to Oct 2024; Sideways from Nov 2024 to Feb 2025; Rising from Feb 2025 to Mar 2025; Sideways in Apr 2025; Sideways from May 2025 to Jul 2025; Rising from Jul 2025 to Mar 2026; Sideways from Mar 2026 to Aug 2026; Falling from Aug 2026 to Nov 2026.

Price stage: Falling from Oct 2021 to Dec 2022; Sideways from Jan 2023 to Jul 2023; Sideways from Aug 2023 to Jan 2024; Sideways from Jan 2024 to Feb 2024; Falling from Mar 2024 to Jun 2024; Sideways from Jul 2024 to Oct 2024; Sideways from Nov 2024 to Feb 2025; Rising from Feb 2025 to Apr 2025; Sideways from May 2025 to Jul 2025; Rising from Aug 2025 to Feb 2026; Sideways from Mar 2026 to Aug 2026; Falling from Aug 2026 to Nov 2026.

Price stage: Sideways from Dec 2017 to Jan 2018; Rising from Feb 2018 to Jun 2018; Sideways from Jul 2018 to Nov 2018; Sideways from Dec 2018 to Mar 2019; Rising from Mar 2019 to Feb 2020; Sideways from Feb 2020 to Jul 2020; Falling from Jul 2020 to Nov 2020; Sideways from Dec 2020 to Jul 2021; Sideways from Aug 2021 to Oct 2021; Falling from Nov 2021 to Dec 2022; Sideways from Jan 2023 to Jul 2023; Sideways from Aug 2023 to Jan 2024; Sideways from Jan 2024 to Mar 2024; Falling from Mar 2024 to Jun 2024; Sideways from Jul 2024 to Oct 2024; Sideways from Nov 2024 to Apr 2025; Sideways from May 2025 to Jul 2025; Rising from Jul 2025 to Feb 2026; Sideways from Mar 2026 to Aug 2026; Falling from Aug 2026 to Nov 2026.

Week by week since 2016: did it beat the S&P 500 over the past 13 weeks?

Ahead in 209 of 527 weeks

Week by week since 2016: did it beat the S&P 500 over the past 13 weeks?
Week13-week return vs S&P 500
8 Jul 2016no S&P 500 reading
15 Jul 2016no S&P 500 reading
22 Jul 2016no S&P 500 reading
29 Jul 2016no S&P 500 reading
5 Aug 2016no S&P 500 reading
12 Aug 2016no S&P 500 reading
19 Aug 2016no S&P 500 reading
26 Aug 2016no S&P 500 reading
2 Sep 2016no S&P 500 reading
9 Sep 2016no S&P 500 reading
16 Sep 2016no S&P 500 reading
23 Sep 2016no S&P 500 reading
30 Sep 2016no S&P 500 reading
7 Oct 2016−10.0%
14 Oct 2016−10.3%
21 Oct 2016−10.2%
28 Oct 2016−8.6%
4 Nov 2016−10.7%
11 Nov 2016−17.3%
18 Nov 2016−16.8%
25 Nov 2016−16.4%
2 Dec 2016−15.1%
9 Dec 2016−14.5%
16 Dec 2016−14.4%
23 Dec 2016−14.8%
30 Dec 2016−11.6%
6 Jan 2017−9.4%
13 Jan 2017−6.9%
20 Jan 2017−6.5%
27 Jan 2017−5.1%
3 Feb 2017−1.7%
10 Feb 2017+2.8%
17 Feb 2017+2.2%
24 Feb 2017+2.0%
3 Mar 2017−1.7%
10 Mar 2017−1.9%
17 Mar 2017−0.5%
24 Mar 2017+1.6%
31 Mar 2017−2.6%
7 Apr 2017−0.5%
13 Apr 2017+1.3%
21 Apr 2017+2.5%
28 Apr 2017+5.1%
5 May 2017+6.3%
12 May 2017+10.1%
19 May 2017+12.7%
26 May 2017+11.5%
2 Jun 2017+14.4%
9 Jun 2017+10.8%
16 Jun 2017+10.4%
23 Jun 2017+7.9%
30 Jun 2017+10.1%
7 Jul 2017+7.1%
14 Jul 2017+4.7%
21 Jul 2017+4.0%
28 Jul 2017+2.7%
4 Aug 2017−0.2%
11 Aug 2017+0.4%
18 Aug 2017+0.1%
25 Aug 2017+1.9%
1 Sep 2017+0.1%
8 Sep 2017+5.4%
15 Sep 2017+1.8%
22 Sep 2017−0.6%
29 Sep 2017+0.5%
6 Oct 2017+1.9%
13 Oct 2017+6.0%
20 Oct 2017+5.3%
27 Oct 2017+3.0%
3 Nov 2017+2.0%
10 Nov 2017−3.2%
17 Nov 2017−5.6%
24 Nov 2017−6.9%
1 Dec 2017−7.9%
8 Dec 2017−10.2%
15 Dec 2017−12.5%
22 Dec 2017−10.1%
29 Dec 2017−10.0%
5 Jan 2018−10.5%
12 Jan 2018−17.7%
19 Jan 2018−17.7%
26 Jan 2018−13.3%
2 Feb 2018−10.8%
9 Feb 2018−5.2%
16 Feb 2018−3.8%
23 Feb 2018−4.4%
2 Mar 2018−1.9%
9 Mar 2018−1.2%
16 Mar 2018+5.6%
23 Mar 2018+9.7%
29 Mar 2018+10.4%
6 Apr 2018+10.4%
13 Apr 2018+13.3%
20 Apr 2018+15.0%
27 Apr 2018+12.1%
4 May 2018+3.5%
11 May 2018−0.9%
18 May 2018−0.8%
25 May 2018+1.5%
1 Jun 2018−0.3%
8 Jun 2018−1.1%
15 Jun 2018−3.3%
22 Jun 2018−4.8%
29 Jun 2018−4.7%
6 Jul 2018−10.7%
13 Jul 2018−11.3%
20 Jul 2018−12.8%
27 Jul 2018−11.8%
3 Aug 2018−6.4%
10 Aug 2018−5.3%
17 Aug 2018−5.3%
24 Aug 2018−7.1%
31 Aug 2018−7.4%
7 Sep 2018−4.9%
14 Sep 2018−3.6%
21 Sep 2018−8.3%
28 Sep 2018−8.3%
5 Oct 2018−3.9%
12 Oct 2018−2.7%
19 Oct 2018−4.6%
26 Oct 2018−5.0%
2 Nov 2018+4.9%
9 Nov 2018+6.8%
16 Nov 2018+6.5%
23 Nov 2018+9.5%
30 Nov 2018+9.0%
7 Dec 2018+12.4%
14 Dec 2018+11.2%
21 Dec 2018+14.9%
28 Dec 2018+15.2%
4 Jan 2019+14.5%
11 Jan 2019+15.1%
18 Jan 2019+17.2%
25 Jan 2019+15.5%
1 Feb 2019+4.9%
8 Feb 2019+11.5%
15 Feb 2019+2.5%
22 Feb 2019−0.6%
1 Mar 2019+2.6%
8 Mar 2019−2.7%
15 Mar 2019−2.7%
22 Mar 2019−4.9%
29 Mar 2019−6.3%
5 Apr 2019−6.2%
12 Apr 2019−7.8%
18 Apr 2019−8.8%
26 Apr 2019−7.4%
3 May 2019+2.9%
10 May 2019−0.3%
17 May 2019+6.5%
24 May 2019+9.6%
31 May 2019+10.6%
7 Jun 2019+7.7%
14 Jun 2019+5.0%
21 Jun 2019+4.5%
28 Jun 2019+4.8%
5 Jul 2019+5.3%
12 Jul 2019+7.1%
19 Jul 2019+11.2%
26 Jul 2019+11.2%
2 Aug 2019+8.5%
9 Aug 2019+5.9%
16 Aug 2019+10.0%
23 Aug 2019+10.3%
30 Aug 2019+7.2%
6 Sep 2019+8.6%
13 Sep 2019+5.0%
20 Sep 2019+7.6%
27 Sep 2019+9.3%
4 Oct 2019+9.9%
11 Oct 2019+9.6%
18 Oct 2019+10.4%
25 Oct 2019−2.0%
1 Nov 2019−10.3%
8 Nov 2019−13.0%
15 Nov 2019−14.7%
22 Nov 2019−15.4%
29 Nov 2019−14.1%
6 Dec 2019−14.9%
13 Dec 2019−6.3%
20 Dec 2019−7.4%
27 Dec 2019−8.2%
3 Jan 2020−7.0%
10 Jan 2020−6.2%
17 Jan 2020−8.2%
24 Jan 2020+7.3%
31 Jan 2020+6.5%
7 Feb 2020+6.0%
14 Feb 2020+2.5%
21 Feb 2020+7.2%
28 Feb 2020+6.4%
6 Mar 2020+5.9%
13 Mar 2020−10.5%
20 Mar 2020−7.2%
27 Mar 2020−5.9%
3 Apr 2020−6.3%
9 Apr 2020−2.5%
17 Apr 2020−6.5%
24 Apr 2020−9.9%
1 May 2020−8.2%
8 May 2020−3.8%
15 May 2020−5.9%
22 May 2020−7.6%
29 May 2020−12.2%
5 Jun 2020−7.4%
12 Jun 2020+4.8%
19 Jun 2020−2.4%
26 Jun 2020−11.5%
2 Jul 2020−9.8%
10 Jul 2020−18.9%
17 Jul 2020−6.5%
24 Jul 2020−6.3%
31 Jul 2020−11.5%
7 Aug 2020−11.5%
14 Aug 2020−9.0%
21 Aug 2020−18.5%
28 Aug 2020−15.1%
4 Sep 2020−16.6%
11 Sep 2020−10.4%
18 Sep 2020−10.5%
25 Sep 2020−10.3%
2 Oct 2020−6.4%
9 Oct 2020−5.8%
16 Oct 2020−13.6%
23 Oct 2020−14.5%
30 Oct 2020−11.9%
6 Nov 2020−16.2%
13 Nov 2020−7.8%
20 Nov 2020−5.3%
27 Nov 2020−8.3%
4 Dec 2020−4.5%
11 Dec 2020−10.4%
18 Dec 2020−5.4%
24 Dec 2020+0.4%
31 Dec 2020−5.6%
8 Jan 2021+1.9%
15 Jan 2021+1.1%
22 Jan 2021+7.1%
29 Jan 2021+7.2%
5 Feb 2021+5.1%
12 Feb 2021−0.7%
19 Feb 2021−4.5%
26 Feb 2021−4.9%
5 Mar 2021−10.9%
12 Mar 2021−9.1%
19 Mar 2021−14.8%
26 Mar 2021−17.7%
1 Apr 2021−16.6%
9 Apr 2021−21.5%
16 Apr 2021−17.0%
23 Apr 2021−17.5%
30 Apr 2021−10.6%
7 May 2021−6.3%
14 May 2021−8.5%
21 May 2021−0.2%
28 May 2021+1.6%
4 Jun 2021+0.0%
11 Jun 2021+3.8%
18 Jun 2021+4.7%
25 Jun 2021+8.5%
2 Jul 2021+7.4%
9 Jul 2021+7.3%
16 Jul 2021−0.2%
23 Jul 2021−2.0%
30 Jul 2021−10.3%
6 Aug 2021−17.9%
13 Aug 2021−18.1%
20 Aug 2021−17.9%
27 Aug 2021−18.6%
3 Sep 2021−15.8%
10 Sep 2021−20.3%
17 Sep 2021−19.0%
24 Sep 2021−20.7%
1 Oct 2021−20.5%
8 Oct 2021−22.0%
15 Oct 2021−18.5%
22 Oct 2021−19.8%
29 Oct 2021−19.8%
5 Nov 2021−8.7%
12 Nov 2021−11.7%
19 Nov 2021−16.8%
26 Nov 2021−16.7%
3 Dec 2021−16.4%
10 Dec 2021−17.9%
17 Dec 2021−15.5%
23 Dec 2021−12.8%
31 Dec 2021−10.9%
7 Jan 2022−3.2%
14 Jan 2022−5.7%
21 Jan 2022−1.6%
28 Jan 2022−0.1%
4 Feb 2022−4.7%
11 Feb 2022−2.6%
18 Feb 2022+1.5%
25 Feb 2022+13.0%
4 Mar 2022+7.1%
11 Mar 2022+5.4%
18 Mar 2022+5.2%
25 Mar 2022−0.6%
1 Apr 2022−2.1%
8 Apr 2022−5.5%
14 Apr 2022−4.9%
22 Apr 2022−0.3%
29 Apr 2022+3.8%
6 May 2022+3.8%
13 May 2022+4.9%
20 May 2022+8.4%
27 May 2022−3.0%
3 Jun 2022−0.1%
10 Jun 2022+3.8%
17 Jun 2022+1.0%
24 Jun 2022+2.0%
1 Jul 2022+2.4%
8 Jul 2022−1.7%
15 Jul 2022+0.2%
22 Jul 2022−6.1%
29 Jul 2022−20.2%
5 Aug 2022−19.9%
12 Aug 2022−22.6%
19 Aug 2022−30.0%
26 Aug 2022−24.9%
2 Sep 2022−16.9%
9 Sep 2022−16.7%
16 Sep 2022−17.6%
23 Sep 2022−15.7%
30 Sep 2022−10.7%
7 Oct 2022−9.6%
14 Oct 2022−10.6%
21 Oct 2022−13.4%
28 Oct 2022−1.0%
4 Nov 2022+1.9%
11 Nov 2022+3.6%
18 Nov 2022+8.9%
25 Nov 2022+13.4%
2 Dec 2022+5.9%
9 Dec 2022+7.3%
16 Dec 2022+9.7%
23 Dec 2022+15.1%
30 Dec 2022+8.7%
6 Jan 2023+18.6%
13 Jan 2023+15.1%
20 Jan 2023+17.2%
27 Jan 2023+12.2%
3 Feb 2023+9.7%
10 Feb 2023+7.2%
17 Feb 2023+5.4%
24 Feb 2023+9.5%
3 Mar 2023+8.8%
10 Mar 2023+7.6%
17 Mar 2023+5.0%
24 Mar 2023+0.1%
31 Mar 2023−3.3%
6 Apr 2023−5.8%
14 Apr 2023+1.4%
21 Apr 2023+7.9%
28 Apr 2023+13.6%
5 May 2023+10.9%
12 May 2023+12.4%
19 May 2023+11.6%
26 May 2023−2.1%
2 Jun 2023−3.0%
9 Jun 2023−6.6%
16 Jun 2023+0.9%
23 Jun 2023+3.3%
30 Jun 2023+7.3%
7 Jul 2023−2.7%
14 Jul 2023−5.5%
21 Jul 2023−12.1%
28 Jul 2023−16.0%
4 Aug 2023−19.1%
11 Aug 2023−18.4%
18 Aug 2023−19.0%
25 Aug 2023−15.8%
1 Sep 2023−16.6%
8 Sep 2023−15.4%
15 Sep 2023−19.1%
22 Sep 2023−18.4%
29 Sep 2023−19.6%
6 Oct 2023−18.5%
13 Oct 2023−22.3%
20 Oct 2023−21.1%
27 Oct 2023−19.3%
3 Nov 2023−13.0%
10 Nov 2023−12.7%
17 Nov 2023−9.0%
24 Nov 2023−7.0%
1 Dec 2023−3.6%
8 Dec 2023−4.3%
15 Dec 2023−5.3%
22 Dec 2023−2.5%
29 Dec 2023−1.1%
5 Jan 2024+2.9%
12 Jan 2024+9.2%
19 Jan 2024+11.1%
26 Jan 2024+11.0%
2 Feb 2024+1.9%
9 Feb 2024−0.2%
16 Feb 2024−1.3%
23 Feb 2024+0.4%
1 Mar 2024−11.6%
8 Mar 2024−6.0%
15 Mar 2024−6.5%
22 Mar 2024−14.0%
28 Mar 2024−17.1%
5 Apr 2024−18.5%
12 Apr 2024−20.4%
19 Apr 2024−18.0%
26 Apr 2024−17.1%
3 May 2024−14.4%
10 May 2024−13.3%
17 May 2024−13.0%
24 May 2024−18.1%
31 May 2024−7.0%
7 Jun 2024−9.1%
14 Jun 2024−12.8%
21 Jun 2024−7.8%
28 Jun 2024−6.3%
5 Jul 2024+2.6%
12 Jul 2024+9.9%
19 Jul 2024+7.8%
26 Jul 2024+11.2%
2 Aug 2024+18.7%
9 Aug 2024+16.1%
16 Aug 2024+11.2%
23 Aug 2024+18.0%
30 Aug 2024+14.9%
6 Sep 2024+18.3%
13 Sep 2024+20.9%
20 Sep 2024+16.4%
27 Sep 2024+20.6%
4 Oct 2024+8.6%
11 Oct 2024−3.5%
18 Oct 2024−2.0%
25 Oct 2024−8.3%
1 Nov 2024−24.3%
8 Nov 2024−30.9%
15 Nov 2024−23.3%
22 Nov 2024−24.0%
29 Nov 2024−23.3%
6 Dec 2024−31.9%
13 Dec 2024−26.5%
20 Dec 2024−23.4%
27 Dec 2024−24.5%
3 Jan 2025−21.9%
10 Jan 2025−15.9%
17 Jan 2025−16.7%
24 Jan 2025−16.6%
31 Jan 2025−4.8%
7 Feb 2025+1.1%
14 Feb 2025−0.8%
21 Feb 2025+2.5%
28 Feb 2025+13.7%
7 Mar 2025+23.0%
14 Mar 2025+18.8%
21 Mar 2025+18.7%
28 Mar 2025+19.8%
4 Apr 2025+22.4%
11 Apr 2025+16.0%
17 Apr 2025+14.4%
25 Apr 2025+15.6%
2 May 2025+18.6%
9 May 2025+20.9%
16 May 2025+14.9%
23 May 2025+13.0%
30 May 2025+0.8%
6 Jun 2025−2.7%
13 Jun 2025−3.2%
20 Jun 2025−2.9%
27 Jun 2025−2.9%
3 Jul 2025−8.7%
11 Jul 2025+0.3%
18 Jul 2025−2.9%
25 Jul 2025+3.2%
1 Aug 2025−2.0%
8 Aug 2025+14.6%
15 Aug 2025+17.1%
22 Aug 2025+19.5%
29 Aug 2025+19.9%
5 Sep 2025+17.8%
12 Sep 2025+18.4%
19 Sep 2025+16.1%
26 Sep 2025+9.6%
3 Oct 2025+12.9%
10 Oct 2025+11.2%
17 Oct 2025+14.6%
24 Oct 2025+9.2%
31 Oct 2025+9.7%
7 Nov 2025−13.4%
14 Nov 2025−14.1%
21 Nov 2025−14.1%
28 Nov 2025−17.1%
5 Dec 2025−18.0%
12 Dec 2025−17.3%
19 Dec 2025−13.5%
26 Dec 2025−11.0%
2 Jan 2026−11.6%
9 Jan 2026−10.7%
16 Jan 2026−14.1%
23 Jan 2026−10.7%
30 Jan 2026−8.7%
6 Feb 2026+1.5%
13 Feb 2026+9.2%
20 Feb 2026+4.9%
27 Feb 2026+10.5%
6 Mar 2026+4.4%
13 Mar 2026+3.9%
20 Mar 2026+2.0%
27 Mar 2026+3.9%
2 Apr 2026+1.8%
10 Apr 2026+1.8%
17 Apr 2026+2.4%
24 Apr 2026−8.8%
1 May 2026−12.9%
8 May 2026−20.5%
15 May 2026−26.8%
22 May 2026−23.7%
29 May 2026−29.8%
5 Jun 2026−20.5%
12 Jun 2026−19.2%
18 Jun 2026−21.0%
26 Jun 2026−20.0%
2 Jul 2026−19.4%
10 Jul 2026−19.4%
17 Jul 2026−15.6%
24 Jul 2026−6.7%
31 Jul 2026−2.4%
7 Aug 2026−4.3%
14 Aug 2026−4.1%
21 Aug 2026−6.9%
28 Aug 2026−4.1%
4 Sep 2026−10.1%
11 Sep 2026−13.1%
18 Sep 2026−10.4%
25 Sep 2026−16.2%
2 Oct 2026−16.0%
9 Oct 2026−14.4%
16 Oct 2026−7.7%
23 Oct 2026−2.0%
30 Oct 2026−7.1%
4 Nov 2026+8.6%
Each bar is one week, from 2016 to now (527 weeks with a reading). Green means the stock's return over the previous 13 weeks beat the S&P 500; red means it trailed. The colour is strongest at a gap of 25 percentage points or more. A gap means there is no reading for that week.

Over the last 10 years the share price moved −6% while the S&P 500 moved +261%, so it is behind the index over that whole period. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

What dividend does Smith & Nephew pay?

Smith & Nephew plc paid $0.78 per share over the last four reported quarters. The most recent declaration was $0.16 for Jun 2026. At today's price of $32.46 that is a yield of 2.40%, based on dividends already paid, not a forecast.

A dividend is cash paid out for each share. The 12-month total is the four most recent quarters added together.

Dividend per share each quarter: latest $0.16 (Jun 2026)

  • Dividend per share $0.16
Dividend per share each quarter: latest $0.16 (Jun 2026)
QuarterDividend per share
Dec 2021$0.23
Jul 2022$0.14
Dec 2022$0.23
Jul 2023$0.14
Dec 2023$0.23
Jun 2024$0.14
Dec 2024$0.23
Jun 2025$0.15
Dec 2025$0.24
Jun 2026$0.16
Declared dividend per share, $ a share, each reported quarter. 10 quarters on file.

Which stock lists is Smith & Nephew on?

Smith & Nephew is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list.

Is Smith & Nephew profitable?

Smith & Nephew plc earned $303 M of net profit in the Jun 2026 quarter, +3.4% on the same quarter a year earlier. That is the 6th quarter in a row of profit growth. Full-year FY25 profit was $625 M. Over 4 years profit has grown 4.5% a year on average. That is 9.8% of the quarter's revenue.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

The same quarter a year earlier earned $214 M.

For the full year, FY25 profit was $625 M (+51.7% on the year before).

FY25 profit $625 M (+51.7% on the year before), 4.5% a year over 4 years

  • Net profit $625 M
FY25 profit $625 M (+51.7% on the year before), 4.5% a year over 4 years
QuarterNet profit
FY21$524 M
FY22$223 M
FY23$263 M
FY24$412 M
FY25$625 M

Growth on a year earlier

  • Growth on a year earlier 51.7%
Growth on a year earlier
QuarterGrowth on a year earlier
FY21–
FY22−57.4%
FY2317.9%
FY2456.7%
FY2551.7%
Top: net profit each year, $ M. Below: growth on the year before, %. 5-year window. A grey bar is lower than the year before.

Jun 2026: $303 M (+3.4% on a year earlier), the 6th quarter in a row of growth

  • Net profit (quarterly) $303 M
Jun 2026: $303 M (+3.4% on a year earlier), the 6th quarter in a row of growth
QuarterNet profit (quarterly)
Dec 2020$348 M
Jul 2021$205 M
Dec 2021$319 M
Jul 2022$177 M
Dec 2022$46.0 M
Jul 2023$172 M
Dec 2023$91.0 M
Jun 2024$214 M
Dec 2024$198 M
Jun 2025$293 M
Dec 2025$332 M
Jun 2026$303 M

Growth on a year earlier

  • Growth on a year earlier 3.4%
Growth on a year earlier
QuarterGrowth on a year earlier
Dec 202019.6%
Jul 2021105%
Dec 2021−8.3%
Jul 2022−13.7%
Dec 2022−85.6%
Jul 2023−2.8%
Dec 202397.8%
Jun 202424.4%
Dec 2024117.6%
Jun 202536.9%
Dec 202567.7%
Jun 20263.4%
Top: net profit each quarter, $ M. Below: growth on the same quarter a year earlier, %. Last 12 quarters. A grey bar is lower than the quarter before.

Why profit moved: revenue changed +4.6% on a year earlier and the margin moved +0.0 percentage points. Sales did the work, and the margin was about flat.

On average over the last four quarters, profit changed +56.4% and revenue +5.7%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra dollar of revenue adds more to profit.

How much revenue does Smith & Nephew make, and is it growing?

Smith & Nephew plc reported $3.1 B of revenue in the Jun 2026 quarter, +4.6% on the same quarter a year earlier. That is the 8th quarter in a row with growth on the year before. Over 4 years it has grown 4.3% a year on average. The last full year, FY25, came in at $6.2 B.

Revenue is everything the company billed its customers in the period.

FY25 revenue was $6.2 B, +6.1% on the year before.

FY25 revenue $6.2 B (+6.1% on the year before), 4.3% a year over 4 years

  • Revenue $6.2 B
FY25 revenue $6.2 B (+6.1% on the year before), 4.3% a year over 4 years
QuarterRevenue
FY21$5.2 B
FY22$5.2 B
FY23$5.5 B
FY24$5.8 B
FY25$6.2 B

Growth on a year earlier

  • Growth on a year earlier 6.1%
Growth on a year earlier
QuarterGrowth on a year earlier
FY21–
FY220.1%
FY236.4%
FY244.7%
FY256.1%
Top: revenue each year, $ B. Below: growth on the year before, %. 5-year window. A grey bar is lower than the year before.

Jun 2026: $3.1 B (+4.6% on a year earlier), the 8th quarter in a row of growth

  • Revenue (quarterly) $3.1 B
Jun 2026: $3.1 B (+4.6% on a year earlier), the 8th quarter in a row of growth
QuarterRevenue (quarterly)
Dec 2020$2.5 B
Jul 2021$2.6 B
Dec 2021$2.6 B
Jul 2022$2.6 B
Dec 2022$2.6 B
Jul 2023$2.7 B
Dec 2023$2.8 B
Jun 2024$2.8 B
Dec 2024$3.0 B
Jun 2025$3.0 B
Dec 2025$3.2 B
Jun 2026$3.1 B

Growth on a year earlier

  • Growth on a year earlier 4.6%
Growth on a year earlier
QuarterGrowth on a year earlier
Dec 2020−4.8%
Jul 202127.7%
Dec 20213.5%
Jul 20220%
Dec 20220.1%
Jul 20235.2%
Dec 20237.6%
Jun 20243.4%
Dec 20246%
Jun 20254.7%
Dec 20257.4%
Jun 20264.6%
Top: revenue each quarter, $ B. Below: growth on the same quarter a year earlier, %. Last 12 quarters. A grey bar is lower than the quarter before.

Recent pace: the last four quarters grew +5.7% on average, against 4.3% a year over the longer run, so this year is growing faster than its own long-run rate.

Is growth speeding up? Revenue over the last 12 months grew +11.4%, against +8.8% a year over the last 8 quarters (stabilising); profit over the last 12 months grew +115.3%, against +3.6% a year (accelerating).

How much of every $100 of sales does Smith & Nephew keep?

Smith & Nephew plc's operating margin was 14.5% in the Jun 2026 quarter, about the same as the same quarter a year ago. Over the last four quarters it has moved +2.9 percentage points. Across 5 years it has been between 12.6% and 15.2%. The latest quarter is within that range.

Operating margin is what is left from every $100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

In the latest quarter it moved +0.0 percentage points on the same quarter a year ago.

Why the margin moved: operating margin changed +2.9 percentage points on the year while gross margin changed +1.1 points. So the gain came mostly from costs below the gross margin, such as staff and overheads, measured against sales.

FY25: 14.2%, within a range of 12.6% to 15.2% over 5 years

  • Operating margin 14.2%
FY25: 14.2%, within a range of 12.6% to 15.2% over 5 years
QuarterOperating margin
FY2113.7%
FY2212.6%
FY2313.4%
FY2415.2%
FY2514.2%

Change on the year before (points)

  • Change on the year before (points) −1.0 pts
Change on the year before (points)
QuarterChange on the year before (points)
FY21–
FY22−1.1 pts
FY23+0.8 pts
FY24+1.8 pts
FY25−1.0 pts
Operating margin each year, % (top). Below: change on the year before, in percentage points. 5-year window.

Jun 2026: operating margin 14.5% (+0.0 points on a year earlier)

  • Operating margin 14.5%
Jun 2026: operating margin 14.5% (+0.0 points on a year earlier)
QuarterOperating margin
Dec 202011.9%
Jul 20219.2%
Dec 202118.1%
Jul 20229.3%
Dec 202215.7%
Jul 202310.1%
Dec 202316.6%
Jun 202411.6%
Dec 202418.7%
Jun 202514.5%
Dec 202514%
Jun 202614.5%

Change on a year earlier (points)

  • Change on a year earlier (points) 0.0 pts
Change on a year earlier (points)
QuarterChange on a year earlier (points)
Dec 2020−3.0 pts
Jul 2021+9.4 pts
Dec 2021+6.2 pts
Jul 2022+0.1 pts
Dec 2022−2.4 pts
Jul 2023+0.8 pts
Dec 2023+0.9 pts
Jun 2024+1.5 pts
Dec 2024+2.1 pts
Jun 2025+2.9 pts
Dec 2025−4.7 pts
Jun 20260.0 pts
Top: quarterly operating margin, %. Below: change on the same quarter a year earlier, in percentage points. Last 12 quarters. Operating profit as a share of revenue, each quarter.

Is Smith & Nephew's profit turning into cash?

Over the last 3 years, 222% of Smith & Nephew plc's reported profit came in as cash from its operations, so the profit is backed by cash. In FY25 it brought in $1.3 B of operating cash against $625 M of profit. After $433 M of spending on assets, $852 M was left over as free cash.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

FY25: operating cash $1.3 B against profit $625 M; 222% of 3 years' profit came in as cash

  • Operating cash $1.3 B
  • Net profit $625 M
  • Free cash $852 M
FY25: operating cash $1.3 B against profit $625 M; 222% of 3 years' profit came in as cash
QuarterOperating cashNet profitFree cash
FY21$877 M$524 M$469 M
FY22$468 M$223 M$110 M
FY23$608 M$263 M$181 M
FY24$987 M$412 M$606 M
FY25$1.3 B$625 M$852 M
Operating cash flow and net profit each year, $ B. The line is free cash flow: operating cash minus spending on assets. 5-year window, yearly figures.

Jun 2026: operating cash $450 M = 149% of the quarter's profit

  • Operating cash (quarterly) $450 M
Jun 2026: operating cash $450 M = 149% of the quarter's profit
QuarterOperating cash (quarterly)
Dec 2020$862 M
Jul 2021$363 M
Dec 2021$514 M
Jul 2022$207 M
Dec 2022$261 M
Jul 2023$113 M
Dec 2023$495 M
Jun 2024$238 M
Dec 2024$749 M
Jun 2025$396 M
Dec 2025$889 M
Jun 2026$450 M

Operating cash as % of profit

  • Operating cash as % of profit 149%
Operating cash as % of profit
QuarterOperating cash as % of profit
Dec 2020248%
Jul 2021177%
Dec 2021161%
Jul 2022117%
Dec 2022567%
Jul 202366%
Dec 2023544%
Jun 2024111%
Dec 2024378%
Jun 2025135%
Dec 2025268%
Jun 2026149%
Top: operating cash each quarter, $ M. Below: operating cash as a % of net profit; 100% means all of the quarter's profit came in as cash. Last 12 quarters.

Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason.

What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building.

Where does Smith & Nephew's cash go?

Smith & Nephew plc does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $1.2 B on assets over the last 3 years. Averaged over those years that is 6.7% of FY25 revenue a year.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn.

Spending on assets: $1.2 B over the last 3 years.

FY25: capex $433 M, steady spending

  • Capex $433 M
FY25: capex $433 M, steady spending
QuarterCapex
FY21$408 M
FY22$358 M
FY23$427 M
FY24$381 M
FY25$433 M
Capital spending each year, $ M.

Jun 2026: capex $190 M in the quarter

  • Capex (quarterly) $190 M
Jun 2026: capex $190 M in the quarter
QuarterCapex (quarterly)
Dec 2020$255 M
Jul 2021$175 M
Dec 2021$233 M
Jul 2022$173 M
Dec 2022$185 M
Jul 2023$167 M
Dec 2023$260 M
Jun 2024$172 M
Dec 2024$209 M
Jun 2025$139 M
Dec 2025$294 M
Jun 2026$190 M

Free cash

  • Free cash $260 M
Free cash
QuarterFree cash
Dec 2020–
Jul 2021–
Dec 2021$281 M
Jul 2022$34.0 M
Dec 2022$76.0 M
Jul 2023−$54.0 M
Dec 2023$235 M
Jun 2024$66.0 M
Dec 2024$540 M
Jun 2025$257 M
Dec 2025$595 M
Jun 2026$260 M
Top: capital spending each quarter, $ M. Below: free cash flow, $ M. Last 12 quarters.

In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns.

What is Smith & Nephew's P/E ratio, and how does it compare with its own history?

Smith & Nephew plc's P/E is 21.6×, with too little history to compare. This compares the share price with the company’s own past. It does not say what the business is worth.

P/E is the share price divided by a year's profit per share: how many dollars the market pays for each dollar of yearly profit.

P/E 21.6× against a usual —: with too little history to compare

  • P/E 25.1×
P/E 21.6× against a usual —: with too little history to compare
WeekP/E
5 Jan 201810.1×
19 Jan 20189.97×
2 Feb 201810.2×
16 Feb 201810.4×
2 Mar 201810.2×
16 Mar 201810.8×
29 Mar 201810.9×
13 Apr 201810.9×
27 Apr 201811.1×
11 May 201810.2×
25 May 201810.4×
8 Jun 201810.6×
22 Jun 201810.7×
6 Jul 20189.93×
20 Jul 20189.86×
3 Aug 20189.99×
17 Aug 20189.94×
31 Aug 20189.96×
14 Sep 201810.4×
28 Sep 201810.3×
12 Oct 20189.61×
26 Oct 20189.10×
9 Nov 201810.3×
23 Nov 201810.1×
7 Dec 201810.6×
21 Dec 20189.99×
4 Jan 201911.2×
18 Jan 201911.6×
1 Feb 201911.6×
15 Feb 201911.7×
1 Mar 201911.9×
15 Mar 201912.1×
29 Mar 201912.3×
12 Apr 201912.0×
26 Apr 201911.9×
10 May 201913.1×
24 May 201913.0×
7 Jun 201913.3×
21 Jun 201913.4×
5 Jul 201913.4×
19 Jul 201913.4×
2 Aug 201914.1×
16 Aug 201914.3×
30 Aug 201914.8×
13 Sep 201914.4×
27 Sep 201914.8×
11 Oct 201914.5×
25 Oct 201913.5×
8 Nov 201913.2×
22 Nov 201913.6×
6 Dec 201913.6×
20 Dec 201914.8×
3 Jan 202016.7×
17 Jan 202017.1×
31 Jan 202016.7×
14 Feb 202016.6×
28 Feb 202015.6×
13 Mar 202011.9×
27 Mar 202012.2×
9 Apr 202014.0×
24 Apr 202013.4×
8 May 202014.1×
22 May 202014.2×
5 Jun 202015.3×
19 Jun 202014.1×
2 Jul 202015.9×
17 Jul 202016.7×
31 Jul 202016.0×
14 Aug 202016.5×
28 Aug 202016.4×
11 Sep 202016.2×
25 Sep 202015.0×
9 Oct 202016.0×
23 Oct 202015.5×
6 Nov 202014.9×
20 Nov 202015.8×
4 Dec 202016.7×
18 Dec 202016.8×
31 Dec 202017.6×
15 Jan 202117.9×
29 Jan 202117.7×
12 Feb 202118.4×
26 Feb 202116.2×
12 Mar 202116.4×
26 Mar 202115.8×
9 Apr 202116.1×
23 Apr 202117.3×
7 May 202118.4×
21 May 202118.3×
4 Jun 202117.7×
18 Jun 202117.6×
2 Jul 202118.5×
16 Jul 202119.4×
30 Jul 202119.0×
13 Aug 202117.8×
27 Aug 202117.9×
10 Sep 202117.2×
24 Sep 202116.9×
8 Oct 202115.9×
22 Oct 202116.6×
5 Nov 202117.3×
19 Nov 202116.1×
3 Dec 202115.1×
17 Dec 202115.2×
31 Dec 202118.7×
14 Jan 202218.8×
28 Jan 202218.0×
11 Feb 202217.6×
25 Feb 202219.2×
11 Mar 202216.6×
25 Mar 202217.6×
8 Apr 202217.3×
22 Apr 202217.8×
6 May 202217.4×
20 May 202217.3×
3 Jun 202217.0×
17 Jun 202214.9×
1 Jul 202215.1×
15 Jul 202215.0×
29 Jul 202214.2×
12 Aug 202214.4×
26 Aug 202213.0×
9 Sep 202214.3×
23 Sep 202212.3×
7 Oct 202212.5×
21 Oct 202212.7×
4 Nov 202213.3×
18 Nov 202214.1×
2 Dec 202214.9×
16 Dec 202214.5×
30 Dec 202214.7×
13 Jan 202326.4×
27 Jan 202326.0×
10 Feb 202325.8×
24 Feb 202326.7×
10 Mar 202326.5×
24 Mar 202325.6×
6 Apr 202326.3×
21 Apr 202329.4×
5 May 202329.6×
19 May 202329.4×
2 Jun 202327.9×
16 Jun 202329.7×
30 Jun 202329.8×
14 Jul 202338.0×
28 Jul 202337.6×
11 Aug 202334.9×
25 Aug 202332.8×
8 Sep 202332.6×
22 Sep 202331.1×
6 Oct 202329.1×
20 Oct 202327.5×
3 Nov 202329.6×
17 Nov 202331.4×
1 Dec 202332.4×
15 Dec 202332.4×
29 Dec 202333.5×
12 Jan 202449.3×
26 Jan 202450.6×
9 Feb 202450.2×
23 Feb 202450.6×
8 Mar 202449.8×
22 Mar 202447.2×
5 Apr 202444.1×
19 Apr 202443.0×
3 May 202444.6×
17 May 202447.0×
31 May 202445.6×
14 Jun 202445.6×
28 Jun 202444.6×
12 Jul 202447.5×
26 Jul 202448.4×
9 Aug 202450.0×
23 Aug 202450.6×
6 Sep 202450.6×
20 Sep 202450.6×
4 Oct 202450.1×
18 Oct 202449.4×
1 Nov 202442.2×
15 Nov 202441.6×
29 Nov 202443.1×
13 Dec 202442.7×
27 Dec 202441.5×
10 Jan 202531.1×
24 Jan 202532.5×
7 Feb 202532.0×
21 Feb 202533.9×
7 Mar 202538.7×
21 Mar 202536.5×
4 Apr 202534.1×
17 Apr 202533.6×
2 May 202537.1×
16 May 202537.5×
30 May 202537.6×
13 Jun 202538.1×
27 Jun 202539.2×
11 Jul 202533.4×
25 Jul 202534.9×
8 Aug 202539.9×
22 Aug 202541.3×
5 Sep 202542.0×
19 Sep 202540.6×
3 Oct 202540.0×
17 Oct 202540.1×
31 Oct 202540.6×
14 Nov 202536.0×
28 Nov 202536.7×
12 Dec 202536.0×
26 Dec 202536.4×
9 Jan 202628.3×
23 Jan 202628.1×
6 Feb 202629.3×
20 Feb 202630.5×
6 Mar 202628.9×
20 Mar 202626.9×
2 Apr 202627.1×
17 Apr 202629.0×
1 May 202626.3×
15 May 202624.9×
29 May 202625.0×
12 Jun 202625.8×
26 Jun 202625.3×
10 Jul 202623.7×
24 Jul 202623.6×
7 Aug 202623.3×
21 Aug 202622.6×
4 Sep 202622.3×
18 Sep 202621.3×
2 Oct 202620.4×
16 Oct 202622.5×
30 Oct 202623.0×
4 Nov 202625.1×

Earnings per share, 12 months

  • Earnings per share, 12 months $1.29
Earnings per share, 12 months
WeekEarnings per share, 12 months
5 Jan 2018–
19 Jan 2018–
2 Feb 2018–
16 Feb 2018–
2 Mar 2018–
16 Mar 2018–
29 Mar 2018$3.51
13 Apr 2018$3.51
27 Apr 2018$3.51
11 May 2018$3.51
25 May 2018$3.51
8 Jun 2018$3.51
22 Jun 2018$3.51
6 Jul 2018$3.51
20 Jul 2018$3.51
3 Aug 2018$3.51
17 Aug 2018$3.51
31 Aug 2018$3.51
14 Sep 2018$3.51
28 Sep 2018$3.60
12 Oct 2018$3.60
26 Oct 2018$3.60
9 Nov 2018$3.60
23 Nov 2018$3.60
7 Dec 2018$3.60
21 Dec 2018$3.60
4 Jan 2019$3.60
18 Jan 2019$3.60
1 Feb 2019$3.60
15 Feb 2019$3.60
1 Mar 2019$3.60
15 Mar 2019$3.60
29 Mar 2019$3.27
12 Apr 2019$3.27
26 Apr 2019$3.27
10 May 2019$3.27
24 May 2019$3.27
7 Jun 2019$3.27
21 Jun 2019$3.27
5 Jul 2019$3.27
19 Jul 2019$3.27
2 Aug 2019$3.27
16 Aug 2019$3.27
30 Aug 2019$3.27
13 Sep 2019$3.27
27 Sep 2019$3.23
11 Oct 2019$3.23
25 Oct 2019$3.23
8 Nov 2019$3.23
22 Nov 2019$3.23
6 Dec 2019$3.23
20 Dec 2019$3.23
3 Jan 2020$3.23
17 Jan 2020$3.23
31 Jan 2020$3.23
14 Feb 2020$3.23
28 Feb 2020$3.23
13 Mar 2020$3.23
27 Mar 2020$2.88
9 Apr 2020$2.88
24 Apr 2020$2.88
8 May 2020$2.88
22 May 2020$2.88
5 Jun 2020$2.88
19 Jun 2020$2.88
2 Jul 2020$2.88
17 Jul 2020$2.88
31 Jul 2020$2.88
14 Aug 2020$2.88
28 Aug 2020$2.88
11 Sep 2020$2.88
25 Sep 2020$2.49
9 Oct 2020$2.49
23 Oct 2020$2.49
6 Nov 2020$2.49
20 Nov 2020$2.49
4 Dec 2020$2.49
18 Dec 2020$2.49
31 Dec 2020$2.39
15 Jan 2021$2.39
29 Jan 2021$2.39
12 Feb 2021$2.39
26 Feb 2021$2.39
12 Mar 2021$2.39
26 Mar 2021$2.39
9 Apr 2021$2.39
23 Apr 2021$2.39
7 May 2021$2.39
21 May 2021$2.39
4 Jun 2021$2.39
18 Jun 2021$2.39
2 Jul 2021$2.39
16 Jul 2021$2.39
30 Jul 2021$2.39
13 Aug 2021$2.39
27 Aug 2021$2.39
10 Sep 2021$2.39
24 Sep 2021$2.15
8 Oct 2021$2.15
22 Oct 2021$2.15
5 Nov 2021$2.15
19 Nov 2021$2.15
3 Dec 2021$2.15
17 Dec 2021$2.15
31 Dec 2021$1.85
14 Jan 2022$1.85
28 Jan 2022$1.85
11 Feb 2022$1.85
25 Feb 2022$1.85
11 Mar 2022$1.85
25 Mar 2022$1.85
8 Apr 2022$1.85
22 Apr 2022$1.85
6 May 2022$1.85
20 May 2022$1.85
3 Jun 2022$1.85
17 Jun 2022$1.85
1 Jul 2022$1.85
15 Jul 2022$1.85
29 Jul 2022$1.85
12 Aug 2022$1.85
26 Aug 2022$1.85
9 Sep 2022$1.85
23 Sep 2022$1.83
7 Oct 2022$1.83
21 Oct 2022$1.83
4 Nov 2022$1.83
18 Nov 2022$1.83
2 Dec 2022$1.83
16 Dec 2022$1.83
30 Dec 2022$1.83
13 Jan 2023$1.83
27 Jan 2023$1.83
10 Feb 2023$1.83
24 Feb 2023$1.83
10 Mar 2023$1.83
24 Mar 2023$1.83
6 Apr 2023$1.08
21 Apr 2023$1.08
5 May 2023$1.08
19 May 2023$1.08
2 Jun 2023$1.08
16 Jun 2023$1.08
30 Jun 2023$1.08
14 Jul 2023$1.08
28 Jul 2023$1.08
11 Aug 2023$1.08
25 Aug 2023$1.08
8 Sep 2023$1.08
22 Sep 2023$0.81
6 Oct 2023$0.81
20 Oct 2023$0.81
3 Nov 2023$0.81
17 Nov 2023$0.81
1 Dec 2023$0.81
15 Dec 2023$0.81
29 Dec 2023$0.81
12 Jan 2024$0.81
26 Jan 2024$0.81
9 Feb 2024$0.81
23 Feb 2024$0.81
8 Mar 2024$0.81
22 Mar 2024$0.56
5 Apr 2024$0.56
19 Apr 2024$0.56
3 May 2024$0.56
17 May 2024$0.56
31 May 2024$0.56
14 Jun 2024$0.56
28 Jun 2024$0.56
12 Jul 2024$0.56
26 Jul 2024$0.56
9 Aug 2024$0.56
23 Aug 2024$0.56
6 Sep 2024$0.56
20 Sep 2024$0.60
4 Oct 2024$0.60
18 Oct 2024$0.60
1 Nov 2024$0.60
15 Nov 2024$0.60
29 Nov 2024$0.60
13 Dec 2024$0.60
27 Dec 2024$0.60
10 Jan 2025$0.60
24 Jan 2025$0.60
7 Feb 2025$0.60
21 Feb 2025$0.60
7 Mar 2025$0.60
21 Mar 2025$0.60
4 Apr 2025$0.77
17 Apr 2025$0.77
2 May 2025$0.77
16 May 2025$0.77
30 May 2025$0.77
13 Jun 2025$0.77
27 Jun 2025$0.77
11 Jul 2025$0.77
25 Jul 2025$0.77
8 Aug 2025$0.77
22 Aug 2025$0.77
5 Sep 2025$0.77
19 Sep 2025$0.91
3 Oct 2025$0.91
17 Oct 2025$0.91
31 Oct 2025$0.91
14 Nov 2025$0.91
28 Nov 2025$0.91
12 Dec 2025$0.91
26 Dec 2025$0.91
9 Jan 2026$0.91
23 Jan 2026$0.91
6 Feb 2026$0.91
20 Feb 2026$0.91
6 Mar 2026$0.91
20 Mar 2026$0.91
2 Apr 2026$1.19
17 Apr 2026$1.19
1 May 2026$1.19
15 May 2026$1.19
29 May 2026$1.19
12 Jun 2026$1.19
26 Jun 2026$1.19
10 Jul 2026$1.19
24 Jul 2026$1.19
7 Aug 2026$1.19
21 Aug 2026$1.19
4 Sep 2026$1.19
18 Sep 2026$1.29
2 Oct 2026$1.29
16 Oct 2026$1.29
30 Oct 2026$1.29
4 Nov 2026$1.29
Top: P/E each week. Below: earnings per share, trailing twelve months, a step line that moves once a quarter; 8.8 years of history; short peaks above 51× are drawn at the top edge.
21.6×P/E · too little history to compare
2.37PEG · today, derived from 3-year earnings growth

Why the multiple is where it is: over the past year earnings per share moved +52.3% while the price moved −2.3%. Earnings did better than the price, which pulled the multiple down within its own range.

Where the price move came from: over 5 years the price moved −2.7% a year; about −9.7% a year came from earnings growth and about +7.0 percentage points from the multiple (the market paying more). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple.

In short: there is too little history to say whether the multiple is high or low for this company, so the earnings trend underneath matters more than the multiple.

Is the Smith & Nephew business getting better or worse?

Smith & Nephew plc's business is turning around. EPS growth has swung from −67.3% at its low to +116.1%, improving for 4 quarters in a row, with ROCE steady at 21.2%. This is based on 12 quarters of 4 measures.

Every business is somewhere on a path of getting better or worse, and this section names where. The last 12 quarters of growth in revenue, profit and earnings per share, plus the return the business earns on its capital, are read as lines. Getting worse: the lines are falling. Turning around: a low point has just formed and the last few quarters are rising from it. Getting better: the rise from the low has lasted. Growing steadily: steady growth with healthy returns. Slowing from a peak: still high, but slowing. When the lines disagree the result is mixed; too little history means no reading. CAGR (compound annual growth rate) is the steady yearly rate that would turn the starting value into the latest one. It is the fairest way to compare growth over different periods. If the 1-year figure is much bigger than the 10-year one, recent growth is running faster than the long-run trend. A dash means there is no figure for that period, or the starting year was a loss, where a growth rate means nothing.

Growth year by year: revenue +6.1% in FY25, profit +51.7%

  • Revenue growth 6.1%
Growth year by year: revenue +6.1% in FY25, profit +51.7%
QuarterRevenue growth
FY21–
FY220.1%
FY236.4%
FY244.7%
FY256.1%

Profit growth, EPS growth

  • Profit growth 51.7%
  • EPS growth 52.3%
Profit growth, EPS growth
QuarterProfit growthEPS growth
FY21––
FY22−57.4%−57.3%
FY2317.9%18%
FY2456.7%56.1%
FY2551.7%52.3%
Growth on the year before, each year, %. Top: revenue. Below: net profit and earnings per share, on their own scale because profit growth swings much more. Zero line drawn.

Three growth lines over twelve quarters: revenue stabilising, profit accelerating

  • Revenue 11.4%
Three growth lines over twelve quarters: revenue stabilising, profit accelerating
QuarterRevenue
Dec 20200.3%
Jul 2021−0.1%
Dec 2021−2.7%
Jul 20227.3%
Dec 20227.5%
Jul 20237.6%
Dec 202310.2%
Jun 20246.3%
Dec 20248.9%
Jun 20259.7%
Dec 202511.2%
Jun 202611.4%

Profit, EPS

  • Profit 115.3%
  • EPS 116.1%
Profit, EPS
QuarterProfitEPS
Dec 2020−26.7%−26.8%
Jul 2021−33.3%−33.4%
Dec 2021−23%−35.7%
Jul 2022−3.7%−26.5%
Dec 2022−28.7%−54.7%
Jul 2023−24.4%−62.2%
Dec 2023−50%−70%
Jun 2024−50.1%−67.3%
Dec 2024−9.6%−28.9%
Jun 202511.5%11.3%
Dec 2025113.4%113.6%
Jun 2026115.3%116.1%
Growth on a year earlier, % at each quarter end. Top: revenue. Below: profit and earnings per share, on their own scale because they swing much more. Each is measured over the last 12 months. A gap means there is no reading for that quarter.

ROCE: the return line, worked out each quarter

  • ROCE 21.2%
ROCE: the return line, worked out each quarter
QuarterROCE
Dec 20203.7%
Jul 202111.4%
Dec 202112.2%
Jul 202215.7%
Dec 202216.8%
Jul 202316.6%
Dec 202316.9%
Jun 202417.7%
Dec 202419.1%
Jun 202520.7%
Dec 202521.3%
Jun 202621.2%
Operating profit over the last 12 months (before interest and tax) as a share of average capital employed (total assets minus current liabilities), %.
Steady highRevenue growth · latest +11.4%, range −2.7% to +11.4%
FlatProfit growth · latest +115.3%, range −50.1% to +115.3%
RecoveringEPS growth · latest +116.1%, range −70.0% to +116.1%
Steady highROCE · latest 21.2%, range 3.7% to 21.3%

Why it matters: a turn in growth is often where a bigger change starts. The lines say a turn is forming, so the question is whether the next quarters confirm it.

Compound annual growth rate (%)

Compound annual growth rate over each period, %. Revenue, profit and EPS come from yearly figures; the stock price row is price growth over the same periods. A dash means no figure for that period, or the starting year was a loss.

Compound annual growth rate (%)
Measure1yr3yr5yr10yr
Revenue+6.1%+5.7%——
Profit+51.7%+41.0%——
EPS+52.3%+41.1%——
Stock price−2.3%+10.5%−2.7%+1.3%
+4.6%Revenue growth (Jun 2026) · latest quarter against a year ago
+3.4%Profit growth (Jun 2026) · latest quarter against a year ago
4.3%Revenue, 4 years · yearly growth over the long run

How much does Smith & Nephew earn on its capital?

Smith & Nephew plc earned a ROE of 12% in FY25. That is up from a low of 4% in FY22. Its return on capital used (ROIC) is 1.9 percentage points above its cost of capital, so growth here adds value, not just size. It comes from a 10.1% net margin and 0.59× asset turnover (sales divided by assets).

Return on equity (ROE) is the profit the business earns on its shareholders’ money. We do not have the full capital split, so ROE is the longest history we can draw here.

Why the return is what it is (FY25): a 10.1% net margin × 0.59× asset turnover × 1.98× leverage (assets divided by equity) ≈ 11.8% on equity. The margin does its share; borrowing is a big part of it.

The key test, return on capital used minus the cost of capital: 8.7% − 6.8% = +1.9 percentage points. The 6.8% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. Positive but thin: it creates value with little room for error.

FY25: ROE 12%, the climb back from FY22's 4%

  • ROE 11.8%
  • ROIC (annual) 8.8%
  • Cost of capital 6.8%
FY25: ROE 12%, the climb back from FY22's 4%
QuarterROEROIC (annual)Cost of capital
FY219.4%8.6%6.8%
FY224.2%8.1%6.8%
FY235%8.5%6.8%
FY247.8%9.2%6.8%
FY2511.8%8.8%6.8%
Return on equity each year, % (line); ROIC each year, % (line). 5-year window, low years included. The flat line is the 6.8% cost of capital used on this page.

Mar 2026: ROIC 7.4% (last 12 months) against a 6.8% cost of capital

  • ROIC (12 months) 7.4%
  • ROE (12 months) 10.5%
  • Cost of capital 6.8%
Mar 2026: ROIC 7.4% (last 12 months) against a 6.8% cost of capital
QuarterROIC (12 months)ROE (12 months)Cost of capital
Sep 202253%66.4%6.8%
Apr 202353%66%6.8%
Sep 202329.4%11.5%6.8%
Mar 202429.7%11.9%6.8%
Sep 20246.6%7.2%6.8%
Mar 20257.2%8.3%6.8%
Sep 20256.9%9.8%6.8%
Mar 20267.4%10.5%6.8%
ROIC and ROE over the last 12 months, each quarter, %; the flat line is the cost of capital. Last 8 quarters, lined up with the yearly figure.

Does Smith & Nephew have too much debt?

Smith & Nephew plc has total debt of $3.8 B against shareholder equity of $5.2 B as of Jun 2026, so its debt is 0.73× its equity. Year by year, that ratio went from 0.60 in FY21 to 0.63 in FY25. Keep that borrowing in mind when reading the returns on this page.

Debt-to-equity shows how much of the business is paid for with borrowed money. Lower is safer, and the direction matters as much as the level.

FY25: debt $3.3 B, 0.63× equity

  • Total debt $3.3 B
FY25: debt $3.3 B, 0.63× equity
QuarterTotal debt
FY21$3.3 B
FY22$2.9 B
FY23$3.1 B
FY24$3.3 B
FY25$3.3 B

Debt-to-equity

  • Debt-to-equity 0.63×
Debt-to-equity
QuarterDebt-to-equity
FY210.60×
FY220.55×
FY230.59×
FY240.63×
FY250.63×
Top: total debt each year, $ B. Below: debt-to-equity, ×. 5-year window.

Jun 2026: debt $3.8 B, debt-to-equity 0.73

  • Total debt (quarterly) $3.8 B
Jun 2026: debt $3.8 B, debt-to-equity 0.73
QuarterTotal debt (quarterly)
Dec 2021$3.3 B
Jul 2022$2.9 B
Dec 2022$2.9 B
Jul 2023$3.0 B
Dec 2023$3.1 B
Jun 2024$3.7 B
Dec 2024$3.3 B
Jun 2025$3.5 B
Dec 2025$3.3 B
Jun 2026$3.8 B

Debt-to-equity

  • Debt-to-equity 0.73×
Debt-to-equity
QuarterDebt-to-equity
Dec 20210.60×
Jul 20220.54×
Dec 20220.55×
Jul 20230.58×
Dec 20230.59×
Jun 20240.70×
Dec 20240.63×
Jun 20250.62×
Dec 20250.63×
Jun 20260.73×
Top: total debt each quarter, $ B. Below: debt-to-equity, ×. Last 10 quarters.

What is the Smith & Nephew shareholding pattern?

We have no ownership or short-position figures for Smith & Nephew plc, so this section says so rather than fill the gap. At normal trading volumes, closing those positions would take about 3.2 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead.

There is no quarter-by-quarter list of owners here, so we look at short interest: the share of tradable shares held in short positions, which gain if the price falls.

How far is Smith & Nephew from balance-sheet trouble?

For Smith & Nephew plc, the Z-score is 3.26. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is well clear of danger. It estimates how far the balance sheet is from trouble; it is not a forecast of failure.

The Z-score estimates how far a company is from balance-sheet trouble. Above about 3 is safe; below about 1.8 is the danger zone. It was built for manufacturers, so it is not used for banks and lenders.

Why it matters: a Z-score of 3.26 is well clear of the danger zone, so the balance sheet is not the risk here.

How does Smith & Nephew rank in its industry?

48.1 out of 100, rank 18 of 30 in Medical Devices, with 51% of the evidence available.

Smith & Nephew plc scores 48.1 out of 100 against the 30 companies it is compared with in Medical Devices, ranking 18. Some evidence is missing, so the score is pulled toward the middle on purpose.

The four parts add up to the total exactly: 16.6 + 13.6 + 10.3 + 7.6 = 48.1. This is the same number shown on the industry page; it is worked out once for the whole group and read here.

What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector.

Which companies is Smith & Nephew compared with?

Smith & Nephew ranks 18 of 30 Medical Devices companies on the 4-Factor Sector Score, with 48.1 out of 100.

  1. 1DexCom, Inc.DXCM · turning · Most evidence points up · 81% evidence73.5out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 28.0/35 · Revenue 15.5% · Profit 74.8% · Operating margin change 5.9 points · 83% evidenceCapital efficiency 20.9/25 · ROCE 27.8% · Operating margin 24.3% · 76% evidenceValuation 13.6/20 · P/E 26× · PEG 0.66 · 65% evidenceRelative strength 11.0/20 · Lead over its industry 1.7% · Lead over S&P 500 13.9% · 1 year 60.9% · 100% evidence · 11 of 12 weeks aheadExact sum: 28 + 20.9 + 13.6 + 11 = 73.5 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks.
  2. 2Globus Medical, Inc.GMED · turning · Most evidence points up · 81% evidence65.7out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 28.0/35 · Revenue 19.8% · Profit 50.1% · Operating margin change 7.5 points · 83% evidenceCapital efficiency 17.6/25 · ROCE 14.6% · Operating margin 24.8% · 76% evidenceValuation 14.9/20 · P/E 20× · PEG 0.4 · 65% evidenceRelative strength 5.2/20 · Lead over its industry -13.9% · Lead over S&P 500 -3.6% · 1 year 3.8% · 100% evidence · 1 of 12 weeks aheadExact sum: 28 + 17.6 + 14.9 + 5.2 = 65.7 · What this means: Earnings are strong; relative strength in its sector is -13.9% and the one-year return is 3.8%.
  3. 3Boston Scientific CorporationBSX · basing · Evidence leans up · 81% evidence61.3out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 25.1/35 · Revenue 13.5% · Profit 46.7% · Operating margin change 4.3 points · 83% evidenceCapital efficiency 16.3/25 · ROCE 11.4% · Operating margin 22.9% · 76% evidenceValuation 15.6/20 · P/E 17.3× · PEG 0.37 · 65% evidenceRelative strength 4.3/20 · Lead over its industry -40.1% · Lead over S&P 500 -33.4% · 1 year -54.2% · 100% evidence · 0 of 12 weeks aheadExact sum: 25.1 + 16.3 + 15.6 + 4.3 = 61.3 · What this means: Earnings are strong; relative strength in its sector is -40.1% and the one-year return is -54.2%.
  4. 4Haemonetics CorporationHAE · leader · Evidence leans up · 81% evidence59.0out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 10.8/35 · Revenue 0.3% · Profit -40.5% · Operating margin change 0 points · 83% evidenceCapital efficiency 15.3/25 · ROCE 11.8% · Operating margin 17.9% · 76% evidenceValuation 13.3/20 · P/E 36.5× · PEG 0.49 · 65% evidenceRelative strength 19.6/20 · Lead over its industry 34.9% · Lead over S&P 500 50.5% · 1 year 86.4% · 100% evidence · 12 of 12 weeks aheadExact sum: 10.8 + 15.3 + 13.3 + 19.6 = 59 · What this means: Relative strength against the index is 50.5%, and revenue and profit growth are weak.
  5. 5Insulet CorporationPODD · turning · Evidence leans up · 71% evidence58.6out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 23.8/35 · Revenue 29.4% · Profit 58.6% · Operating margin change -2.5 points · 83% evidenceCapital efficiency 18.9/25 · ROCE 21.3% · Operating margin 16.2% · 76% evidenceValuation 9.3/20 · P/E 28.1× · PEG — · 15% evidenceRelative strength 6.6/20 · Lead over its industry -31.6% · Lead over S&P 500 -24% · 1 year -48.4% · 100% evidence · 1 of 12 weeks aheadExact sum: 23.8 + 18.9 + 9.3 + 6.6 = 58.6 · What this means: Earnings are strong; relative strength in its sector is -31.6% and the one-year return is -48.4%.
  6. 6Glaukos CorporationGKOS · leader · Evidence leans up · 64% evidence56.8out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 22.2/35 · Revenue 41.8% · Profit — · Operating margin change 9.8 points · 62% evidenceCapital efficiency 3.9/25 · ROCE -9.7% · Operating margin -8.5% · 76% evidenceValuation 11.2/20 · P/E -98.1× · PEG — · 15% evidenceRelative strength 19.5/20 · Lead over its industry 51.3% · Lead over S&P 500 69.3% · 1 year 194.2% · 100% evidence · 10 of 12 weeks aheadExact sum: 22.2 + 3.9 + 11.2 + 19.5 = 56.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  7. 7STERIS plcSTE · turning · Evidence leans up · 81% evidence56.1out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 20.2/35 · Revenue 8.3% · Profit 24.7% · Operating margin change 1.4 points · 83% evidenceCapital efficiency 15.4/25 · ROCE 12.2% · Operating margin 19.2% · 76% evidenceValuation 12.5/20 · P/E 25.5× · PEG 1 · 65% evidenceRelative strength 8.0/20 · Lead over its industry -10.4% · Lead over S&P 500 0.1% · 1 year -6% · 100% evidence · 4 of 12 weeks aheadExact sum: 20.2 + 15.4 + 12.5 + 8 = 56.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  8. 8Stryker CorporationSYK · turning · Evidence leans up · 85% evidence55.8out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 20.6/35 · Revenue 7.9% · Profit 23.1% · Operating margin change 0.7 points · 95% evidenceCapital efficiency 18.8/25 · ROCE 15.5% · Operating margin 23% · 76% evidenceValuation 10.4/20 · P/E 29.2× · PEG 1.25 · 65% evidenceRelative strength 6.0/20 · Lead over its industry -14.2% · Lead over S&P 500 -4% · 1 year -4.6% · 100% evidence · 1 of 12 weeks aheadExact sum: 20.6 + 18.8 + 10.4 + 6 = 55.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  9. 9Medtronic plcMDT · breaking out · Evidence leans up · 85% evidence55.1out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 19.1/35 · Revenue 9.8% · Profit 12.3% · Operating margin change 0.6 points · 95% evidenceCapital efficiency 14.3/25 · ROCE 9.4% · Operating margin 19.3% · 76% evidenceValuation 9.3/20 · P/E 20.9× · PEG 1.72 · 65% evidenceRelative strength 12.4/20 · Lead over its industry -2.8% · Lead over S&P 500 8.5% · 1 year 13.9% · 100% evidence · 9 of 12 weeks aheadExact sum: 19.1 + 14.3 + 9.3 + 12.4 = 55.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  10. 10CONMED CorporationCNMD · turning · Evidence leans up · 81% evidence55.0out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 14.7/35 · Revenue 3.4% · Profit -48.2% · Operating margin change 3.2 points · 83% evidenceCapital efficiency 11.5/25 · ROCE 8% · Operating margin 14.6% · 76% evidenceValuation 12.3/20 · P/E 17.4× · PEG 1.18 · 65% evidenceRelative strength 16.5/20 · Lead over its industry 8.5% · Lead over S&P 500 21.2% · 1 year 22% · 100% evidence · 11 of 12 weeks aheadExact sum: 14.7 + 11.5 + 12.3 + 16.5 = 55 · What this means: Relative strength against the index is 21.2%, and revenue and profit growth are weak.
  11. 11Koninklijke Philips N.V.PHG · turning · Evidence leans up · 71% evidence53.6out of 100GrowthCapitalValuationRelative
  12. 12LivaNova PLCLIVN · turning · Evidence leans up · 64% evidence53.0out of 100GrowthCapitalValuationRelative
  13. 13Edwards Lifesciences CorporationEW · turning · Evidence leans up · 81% evidence51.7out of 100GrowthCapitalValuationRelative
  14. 14UFP Technologies, Inc.UFPT · leader · Evidence leans up · 81% evidence50.6out of 100GrowthCapitalValuationRelative
  15. 15Zimmer Biomet Holdings, Inc.ZBH · turning · Evidence leans up · 81% evidence50.0out of 100GrowthCapitalValuationRelative
  16. 16iRhythm Holdings, Inc.IRTC · turning · Evidence leans down · 64% evidence48.4out of 100GrowthCapitalValuationRelative
  17. 17Integer Holdings CorporationITGR · losing its lead · Too little evidence to rank firmly · 56% evidence48.3out of 100GrowthCapitalValuationRelative
  18. 18Smith & Nephew plc this pageSNN · turning · Too little evidence to rank firmly · 51% evidence48.1out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 16.6/35 · Revenue — · Profit — · Operating margin change 0 points · 26% evidenceCapital efficiency 13.6/25 · ROCE 10% · Operating margin 14.5% · 76% evidenceValuation 10.3/20 · P/E 20× · PEG — · 15% evidenceRelative strength 7.6/20 · Lead over its industry -13.9% · Lead over S&P 500 -3.6% · 1 year -2.3% · 100% evidence · 1 of 12 weeks aheadExact sum: 16.6 + 13.6 + 10.3 + 7.6 = 48.1 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose.
  19. 19Bruker CorporationBRKR · turning · Evidence leans down · 71% evidence47.7out of 100GrowthCapitalValuationRelative
  20. 20Butterfly Network, Inc.BFLY · quiet · Evidence leans down · 61% evidence47.7out of 100GrowthCapitalValuationRelative
  21. 21GE HealthCare Technologies Inc.GEHC · turning · Evidence leans down · 81% evidence46.9out of 100GrowthCapitalValuationRelative
  22. 22Neogen CorporationNEOG · turning · Evidence leans down · 67% evidence43.4out of 100GrowthCapitalValuationRelative
  23. 23Axogen, Inc.AXGN · turning · Evidence leans down · 64% evidence42.3out of 100GrowthCapitalValuationRelative
  24. 24Establishment Labs Holdings Inc.ESTA · basing · Evidence leans down · 61% evidence40.7out of 100GrowthCapitalValuationRelative
  25. 25Inspire Medical Systems, Inc.INSP · breaking out · Evidence leans down · 74% evidence39.8out of 100GrowthCapitalValuationRelative
  26. 26NovoCure LimitedNVCR · quiet · Evidence leans down · 61% evidence38.4out of 100GrowthCapitalValuationRelative
  27. 27Bio-Rad Laboratories, Inc.BIO · leader · Evidence leans down · 71% evidence38.1out of 100GrowthCapitalValuationRelative
  28. 28TransMedics Group, Inc.TMDX · quiet · Evidence leans down · 71% evidence36.3out of 100GrowthCapitalValuationRelative
  29. 29Abbott LaboratoriesABT · turning · Most evidence points down · 85% evidence34.5out of 100GrowthCapitalValuationRelative
  30. 30Penumbra, Inc.PEN · turning · Most evidence points down · 81% evidence32.9out of 100GrowthCapitalValuationRelative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read.

The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section.

Related companies: Medical Devices, all 30 compared on one page.

Which companies are close to Smith & Nephew in size?

Smith & Nephew is the 12th largest of 75 Medical Devices companies on Sector Alpha by market value (scores of 4 November 2026). Just above it: STERIS plc, Zimmer Biomet Holdings, Inc. and Glaukos Corporation. Just below it: Penumbra, Inc., Globus Medical, Inc. and Insulet Corporation.

Medical Devices companies close in size

  1. STERIS plc $24.2 billion
  2. Zimmer Biomet Holdings, Inc. $21 billion
  3. Glaukos Corporation $14.6 billion
  4. Smith & Nephew plc $14.4 billion
  5. Penumbra, Inc. $12.7 billion
  6. Globus Medical, Inc. $11.7 billion
  7. Insulet Corporation $11.4 billion

All 75 Medical Devices companies, largest first

Companies close in size in other industries

  1. CNH Industrial N.V. $14.5 billion · Farm & Heavy Construction Machinery
  2. Carpenter Technology Corporation $14.5 billion · Metal Fabrication
  3. Smith & Nephew plc $14.4 billion
  4. GoDaddy Inc. $14.3 billion · Software - Infrastructure
  5. Regency Centers Corporation $14.3 billion · REIT - Retail

What else do people ask about Smith & Nephew?

What were Smith & Nephew's latest quarterly results?

Smith & Nephew plc reported revenue of $3.1 B and net profit of $303 M for the Jun 2026 quarter. Revenue rose 4.6% and profit rose 3.4% compared with a year earlier. Earnings per share were $0.35.

The operating margin was 14.5%, 0.0 percentage points higher than a year earlier (as of 4 November 2026).

What is Smith & Nephew's market cap?

Smith & Nephew plc's market capitalisation is $14.4 B at a stock price of $32.46. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 4 November 2026).

How is Smith & Nephew performing?

Smith & Nephew plc's share price has been stalling near its high for 1 weeks. In its latest quarter, revenue rose 4.6% and profit rose 3.4% compared with a year earlier.

Over the past 13 weeks it has done better than the S&P 500, for 1 week running (as of 4 November 2026).

Will Smith & Nephew's stock price go up?

This page does not forecast Smith & Nephew plc's stock price. What it shows instead: the stock price is $32.46, and it has been stalling near its high for 1 weeks.

Nobody can reliably say which way a price will move, and this site does not try (as of 4 November 2026).

Where is Smith & Nephew in its business cycle?

Smith & Nephew plc's FY25 operating margin was 14.2%, against a 5-year range of 12.6% to 15.2%: the middle of its own range, neither a peak nor a low. The latest quarter was 14.5%.

Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 4 November 2026).

What could break the Smith & Nephew story?

The main question: yearly earnings per share moved +52.3% while the share price moved −2.3%. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 4 November 2026).

Is Smith & Nephew a stock worth studying right now?

What the numbers show: Smith & Nephew plc's earnings have grown faster than its share price. Earnings per share grew +52.3% in a year while the price moved −2.3%. The main open question: whether the price catches up with earnings that have already grown.

Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 4 November 2026).

Where do these numbers come from?

Sector Alpha, written by code from the published numbers. Data as of 4 November 2026.

Every chart on this page is drawn by code from the published figures, with no forecasts and no price opinions.

See the plain-text version of this page.

More lists

Every Sector Alpha list, grouped

X · Instagram · YouTube · About · Newsletter · Newsletter archive
This is research, not advice. We’re not SEBI-registered.